Finance

Lists
Why is ZNTL up ၅.၁၈%?
Dive Deeper
ZNTL:NASDAQ
Zentalis Pharmaceuticals Inc
၂.၆၄ US$
+၅.၁၈%
(+၀.၁၃) 1D
၂.၆၄ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZNTL...
Open
၂.၅၆ US$
High
၂.၆၆ US$
Low
၂.၅၁ US$
Mkt. cap
၂၄.၉၉ ကုဋေ
Avg. vol.
၁.၂၀ သန်း
Volume
၆.၁၂ သိန်း
52-wk high
၆.၉၅ US$
52-wk low
၁.၂၁ US$
EPS
-၁.၉၆ US$
Beta
၁.၉၃
Shares outstanding
၉.၄၇ ကုဋေ
No. of employees
၁၀၆
Open
၂.၅၆ US$
High
၂.၆၆ US$
Low
၂.၅၁ US$
Mkt. cap
၂၄.၉၉ ကုဋေ
Avg. vol.
၁.၂၀ သန်း
Volume
၆.၁၂ သိန်း
52-wk high
၆.၉၅ US$
52-wk low
၁.၂၁ US$
EPS
-၁.၉၆ US$
Beta
၁.၉၃
Shares outstanding
၉.၄၇ ကုဋေ
No. of employees
၁၀၆
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၆ မိနစ်
Learn Why The Bull Case For Werner Enterprises Stock Could Change Following New Credit Facility
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၁၆ မိနစ်
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
24/7 Wall St.
24/7 Wall St.
·
ပြီးခဲ့သည့် ၄ နာရီ
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
About Zentalis Pharmaceuticals Inc
CEO-
Employees၁၀၆
Founded၂၀၁၄
Headquarters-
Sector-
Analyst ratings
Based on 8 analysts giving stock ratings to ZNTL in the past 3 months
Strong buy
Buy
6
Hold
2
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ZNTL in the last 3 months.
Highest
Current ၂.၆၄ US$
၁၁.၀၀ US$ (+၃၁၆.၆၇%)
Average
၈.၁၄ US$ (+၂၀၈.၃၃%)
Lowest
၅.၀၀ US$ (+၈၉.၃၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Upgraded
၈.၀၀ US$
+၂၀၃%
10/05/2026
Yanan Zhu
Wells Fargo
Hold
Maintained
၅.၀၀ US$
+၈၉.၄%
09/29/2026
Matt Phipps
William Blair
Buy
Initiated
-
-
09/15/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
၈.၀၀ US$
+၂၀၃%
08/11/2026
Michael Ulz
Morgan Stanley
Hold
Maintained
၅.၀၀ US$
+၈၉.၄%
08/07/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
၁၀.၀၀ US$
+၂၇၈.၈%
08/07/2026
Michael Schmidt
Guggenheim
Buy
Maintained
၁၀.၀၀ US$
+၂၇၈.၈%
08/07/2026
Michael King
Rodman & Renshaw
Buy
Initiated
၁၁.၀၀ US$
+၃၁၆.၇%
07/23/2026
Jay Olson
Oppenheimer
Buy
Initiated
၉.၀၀ US$
+၂၄၀.၉%
06/15/2026
Unknown Analyst
Wedbush
Hold
Maintained
၄.၀၀ US$
+၅၁.၅%
05/13/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
၉.၀၀ US$
+၂၄၀.၉%
05/13/2026
Eva Fortea Verdejo
Wells Fargo
Hold
Reiterated
၅.၀၀ US$
+၈၉.၄%
05/13/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၂.၃၀ ကုဋေ
၃.၀၇ ကုဋေ
၂.၈၇ ကုဋေ
၃.၅၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၀၈ ကုဋေ
၃.၇၇ သန်း
၉.၁၄ သန်း
၉.၂၃ သန်း
Operating expense
၃.၃၇ ကုဋေ
၃.၄၅ ကုဋေ
၃.၇၉ ကုဋေ
၄.၄၄ ကုဋေ
Total operating expenses
၃.၃၇ ကုဋေ
၃.၄၅ ကုဋေ
၃.၇၉ ကုဋေ
၄.၄၄ ကုဋေ
Operating income
-၃.၃၇ ကုဋေ
-၃.၄၅ ကုဋေ
-၃.၇၉ ကုဋေ
-၄.၄၄ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၂.၆၇ ကုဋေ
-၃.၄၈ ကုဋေ
-၃.၅၂ ကုဋေ
-၄.၂၁ ကုဋေ
EBT excluding unusual items
-၂.၆၇ ကုဋေ
-၃.၄၁ ကုဋေ
-၃.၅၂ ကုဋေ
-၄.၂၁ ကုဋေ
Income tax expense
-
၄.၄၂ သိန်း
၁.၂၀ သိန်း
၁.၃၈ သိန်း
Effective tax rate
-
-၁.၂၇%
-၀.၃၄%
-၀.၃၃%
Other operating expenses
-
-
-
-
Net income
-၂.၆၇ ကုဋေ
-၃.၅၂ ကုဋေ
-၃.၅၄ ကုဋေ
-၄.၂၃ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၃၇
-၀.၄၉
-၀.၅၀
-၀.၅၉
Interest and investment income
၇.၀၄ သန်း
၃.၃၈ သိန်း
၂.၆၂ သန်း
၂.၂၄ သန်း
Interest expense
-
-
-
-
Net interest expenses
၇.၀၄ သန်း
၃.၃၈ သိန်း
၂.၆၂ သန်း
၂.၂၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၃.၃၆ ကုဋေ
-၃.၄၃ ကုဋေ
-၃.၇၇ ကုဋေ
-၄.၄၂ ကုဋေ
Gain or loss from assets sale
-၁.၀၃ သိန်း
-၂.၆၀ သောင်း
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ